Amplification of cancer cell apoptosis in photodynamic therapy-treated tumors by adjuvant ceramide analog LCL29

Lasers in Surgery and Medicine

Volumn 43, Issue 7, 2011, Pages 614-620

  Korbelik, Mladen ^a   Zhang, Wei ^a   Separovic, Duska ^b  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

intracellular calcium; mitochondrial transmembrane potential; sphingolipids; squamous cell carcinoma

Indexed keywords

CASPASE; CERAMIDE DERIVATIVE; DEXTRO ERYTHRO 2' N [6' (1'' PYRIDINIUM)HEXANOYL]SPHINGOSINE BROMIDE; LCL 29; PHOTOSENSITIZING AGENT; SPHINGOLIPID; TEMOPORFIN; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CONTROLLED STUDY; ENZYME ACTIVATION; FLOW CYTOMETRY; HEAD AND NECK CARCINOMA; ILLUMINATION; LIGHT; LIPID METABOLISM; MACROPHAGE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CALCIUM; CARCINOMA, SQUAMOUS CELL; CERAMIDES; CHEMOTHERAPY, ADJUVANT; FLOW CYTOMETRY; HEAD AND NECK NEOPLASMS; MACROPHAGES; MESOPORPHYRINS; MICE; MICE, INBRED C3H; MITOCHONDRIA; PHAGOCYTOSIS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PYRIDINIUM COMPOUNDS;

EID: 80052063474     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.21068     Document Type: Article

References (44)

1. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q,. Photodynamic therapy. J Natl Cancer Inst 1998; 90: 889-905. (Pubitemid 28304157)
2. Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juziene A, Kessel D, Korbelik M, Moan J, Mroz P, Nowis D, Piette J, Wilson BC, Golab J,. Photodynamic therapy of cancer: An update. CA Cancer J Clin (in press).
3. Henderson BW, Dougherty TJ,. How does photodynamic therapy work? Photochem Photobiol 1992; 55: 145-157.
4. Separovic D, Bielawski J, Pierce JS, Merchant S, Tarca AL, Ogretman B, Korbelik M,. Increased tumor dihydroceramide production after Photofrin-PDT alone and improved tumour response after the combination with the ceramide analogue LCL29. Evidence from mouse squamous cell carcinomas. Br J Cancer 2009; 100: 626-632.
5. Separovic D, Bielawski J, Pierce JS, Merchant S, Tarca AL, Bhatti G, Ogretmen B, Korbelik M,. Enhanced tumor cures after Foscan photodynamic therapy combined with the ceramide analog LCL29. Evidence from mouse squamous cell carcinomas for sphingolipids as biomarkers of treatment response. Int J Oncol 2011; 38: 521-527.
6. Hannun YA, Luberto C, Argraves KM,. Enzymes of sphingolipid metabolism: From modular to integrative signaling. Biochemistry 2001; 40: 4893-4903. (Pubitemid 32332534)
7. Hannun YA, Obeid LM,. Principles of bioactive lipid signaling: Lessons from sphingolipids. Nat Rev Mol Cell Biol 2008; 9: 139-150. (Pubitemid 351158911)
8. Ogretmen B, Hannun YA,. Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer 2004; 4: 604-616. (Pubitemid 39025055)
9. Dolgachev V, Farooqui MS, Kulaeva OI, Tainsky MA, Nagy B, Hanada K, Separovic D,. De novo ceramide accumulation due to inhibition of its conversion to complex sphingolipids in apoptotic photosensitized cells. J Biol Chem 2004; 279: 23238-23249. (Pubitemid 38685631)
10. Wispriyono B, Schmelz E, Pelayo H, Hamada K, Separovic D,. A role for de novo sphingolipids in apoptosis of photosensitized cells. Exp Cell Res 2002; 279: 153-165.
11. Separovic D, Semaan L, Tarca AL, Awad Maitah MY, Hanada K, Bielavski J, Villani M, Luberto C,. Suppression of sphingomyelin synthase 1 by small interference RNA is associated with enhanced ceramide production and apoptosis after photodamage. Exp Cell Res 2008; 314: 1860-1868.
12. Spiegel S, Milstein S,. Sphingosine-1-phosphate: An enigmatic signaling lipid. Nat Rev Mol Cell Biol 2003; 4: 397-407.
13. Mora R, Dokic I, Kees T, Hüber CM, Keitel D, Geibig R, Brügge B, Zentgraf H, Brady NR, Régnier-Vigoroux A,. Sphingolipid rheostat alterations related to transformation can be exploited for specific induction of lysosomal cell death in murine and human glioma. Glia 2010; 58: 1364-1383.
14. Kessel D, Oleinick NL,. Photodynamic therapy and cell death pathways. Methods Mol Biol 2010; 635: 35-46.
15. Cecic I, Korbelik M,. Deposition of complement proteins on cells treated by photodynamic therapy in vitro. J Environ Pathol Toxicol Oncol 2006; 25: 189-203. (Pubitemid 43341240)
16. Korbelik M, Stott B, Sun J,. Photodynamic therapy-generated vaccines: Relevance of tumor cell death expression. Br J Cancer 2007; 97: 1381-1387. (Pubitemid 350114797)
17. Khurana D, Martin EA, Kasperbauer JL, O'Malley BW Jr, Salomao DR, Chen L, Strome SE,. Characterization of a spontaneously arising murine squamous cell carcinoma (SCC VII) as a prerequisite for head and neck cancer immunotherapy. Head Neck 2001; 23: 899-906. (Pubitemid 32862295)
18. Korbelik M,. Distribution of disulfonated and tetrasulfonated aluminum phthalocyanine between malignant and host cell populations of murine fibrosarcoma. J Photochem Photobiol B: Biol 1993; 20: 173-181. (Pubitemid 23315040)
19. Griffin RJ, Williams BW, Bischof JC, Olin M, Johnson GL, Lee BW,. Use of a fluorescently labeled poly-caspase inhibitor for in vivo detection of apoptosis related to vascular-targeting agent arsenic trioxide for cancer therapy. Technol Cancer Res Treat 2007; 6: 651-654.
20. Salvioli S, Ardizzoni A, Franceschi C, Cossarizza A,. JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess delta psi changes in intact cells: Implications for studies on mitochondrial functionality during apoptosis. FEBS Lett 1997; 411: 77-82. (Pubitemid 27298375)
21. Diakonova M, Bokoch G, Swanson JA,. Dynamics of cytoskeletal proteins during Fcγ receptor-mediated phagocytosis in macrophages. Mol Biol Cell 2002; 13: 402-411. (Pubitemid 34165070)
22. Marchal S, Bezdatnaya L, Guillemin F,. Modality of cell death induced by Foscan-based photodynamic treatment in human colon adenocarcinoma cell line HT29. Biochemistry (Mosc) 2004; 69: 45-49.
23. Korbelik M,. PDT-associated host response and its role in the therapy outcome. Lasers Surg Med 2006; 38: 500-508.
24. Chiu S-M, Oleinick NL,. Dissociation of mitochondrial depolarization from cytochrome c release during apoptosis induced by photodynamic therapy. Br J Cancer 2001; 84: 1099-1106.
25. Krosl G, Korbelik M, Dougherty GJ,. Induction of immune cell infiltration into murine SCCVII tumor by Photofrin-based photodynamic therapy. Br J Cancer 1995; 71: 549-555.
26. Okazaki T, Bell RM, Hannun YA,. Sphingomyelin turnover induced by vitamin D3 in HL-60 cells. Role in cell differentiation. J Biol Chem 1989; 264: 19076-19080. (Pubitemid 19285812)
27. Kester M, Kolesnick R,. Sphingolipids as therapeutics. Pharmacol Res 2003; 47: 365-371. (Pubitemid 36379198)
28. Zeidan YH, Hannun YA,. Translational aspects of sphingolipid metabolism. Trends Mol Med 2007; 13: 327-336. (Pubitemid 47126985)
29. Szulc ZM, Bielawski J, Gracz H, Gustilo M, Mayroo N, Hannun YA, Obeid LM, Bielawska A,. Tailoring structure-function and targeting properties of ceramides by site-specific cationization. Bioorg Med Chem 2006; 14: 7083-7104. (Pubitemid 44403118)
30. Novgorodov SA, Szulc ZM, Luberto C, Jones JA, Bielawski J, Bielawska A, Hannun YA, Obeid LM,. Positively charged ceramide is a potent inducer of mitochondrial permeabilization. J Biol Chem 2005; 280: 16096-16105. (Pubitemid 40616734)
31. Senkal CE, Ponnusamy S, Rossi MJ, Sundararaj K, Szulc Z, Bielawski J, Bielawska A, Meyer M, Cobanoglu B, Koybasi S, Sinha D, Day TA, Obeid LM, Hannun YA, Ogretmen B,. Potent antitumor activity of a novel cationic pyridinium-ceramide alone or in combination with gemcitabine against human head and neck squamous cell carcinomas in vitro and in vivo. J Pharmacol Exp Ther 2006; 317: 1188-1199. (Pubitemid 43764124)
32. Chen LB,. Mitochondrial membrane potential in living cells. Annu Rev Cell Biol 1988; 4: 155-181. (Pubitemid 19139255)
33. Demaurex N, Distelhorst C,. Cell biology. Apoptosis-The calcium connection. Science 2003; 300: 65-67. (Pubitemid 36423022)
34. Granville DJ, Ruehlmann DO, Choy JC, Cassidy BA, Hunt DW, van Breemen C, McManus BM,. Bcl-2 increases emptying of endoplasmic reticulum Ca2+ stores during photodynamic therapy-induced apoptosis. Cell Calcium 2001; 30: 343-350. (Pubitemid 34030610)
35. Lam M, Oleinick NL, Nieminen A-L,. Photodynamic therapy-induced apoptosis in epidermoid carcinoma cells. J Biol Chem 2001; 276: 47379-47386.
36. Mattson MP, Chan SL,. Calcium orchestrates apoptosis. Nat Cell Biol 2003; 5: 1041-1043. (Pubitemid 37509106)
37. Boehning D, Patterson RL, Sedaghat L, Glebova N, Kurosaki T, Snyder SH,. Cytochrome c binds to inositol (1,4,5) triphosphate receptors, amplifying calcium-dependent apoptosis. Nat Cell Biol 2003; 5: 1051-1061. (Pubitemid 37509111)
38. Majai G, Petrovski G, Fesus L,. Inflammation and the apopto-phagocytic system. Immunol Lett 2006; 104: 94-101. (Pubitemid 43330714)
39. Steubig RW, Yeturu S, Tucillo A, Sun C-H, Berns MW,. Activation of macrophages by Photofrin II during photodynamic therapy. J Photochem Photobiol 1991; 10: 133-145.
40. Korbelik M, Krosl G,. Photofrin accumulations in malignant and host cell populations of various tumours. Br J Cancer 1996; 73: 506-513. (Pubitemid 26055318)
41. Castano AP, Mroz P, Hamblin MR,. Photodynamic therapy and anti-tumor immunity. Nat Rev Cancer 2006; 6: 535-545.
42. Hannun YA, Obeid LM,. Principles of bioactive lipid signaling: Lessons from sphingolipids. Nat Rev 2008; 8: 139-150. (Pubitemid 351158911)
43. Cinque B, Di Marzio L, Centi C, Di Rocco C, Riccardi C, Cifone MG,. Sphingolipids and the immune system. Pharmacol Res 2003; 47: 421-437. (Pubitemid 36379204)
44. 1 overrides regulatory T cell-mediated immune suppression through Akt-mTOR. Nat Immunol 2009; 10: 769-777.